Journal of Postgraduate Medicine, Education and Research

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  58 (2024)
Volume  57 (2023)
Volume  56 (2022)
Volume  55 (2021)
Volume  54 (2020)
Volume  53 (2019)
Volume  52 (2018)
Volume  51 (2017)
Volume  50 (2016)
Volume  49 (2015)
Volume  48 (2014)
Volume  47 (2013)
Volume  46 (2012)
Related articles

VOLUME 47 , ISSUE 1 ( January-March, 2013 ) > List of Articles

REVIEW ARTICLE

90Yttrium Microsphere Radioembolization for Liver Malignancies: A Technical Overview

Sandeep T Laroia

Citation Information : Laroia ST. 90Yttrium Microsphere Radioembolization for Liver Malignancies: A Technical Overview. J Postgrad Med Edu Res 2013; 47 (1):61-64.

DOI: 10.5005/jp-journals-10028-1057

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2013; The Author(s).


Abstract

How to cite this article

Laroia ST. 90Yttrium Microsphere Radioembolization for Liver Malignancies: A Technical Overview. J Postgrad Med Edu Res 2013;47(1):61-64.

PDF Share
  1. Atlanta: American Cancer Society 2004.
  2. Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol 2004;7:431-41.
  3. Recent advances in the pharmacological treatment of colorectal cancer. Expert Opin Investig Drugs 2003;12:423-34.
  4. Surgical treatment of liver metastases. Semin Oncol 2002;29:107-18.
  5. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-29.
  6. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Clin Liver Dis 2005;9:253-79.
  7. Detection of hepatocellular carcinoma: Value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73.
  8. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): Diagnosis and clinical course. Best Pract Res Clin Gastroenterol 2004;18: 1089-104.
  9. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC and JIS) in Japan. Am J Gastroenterol 2005;100:1764-71.
  10. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985;56:918-28.
  11. Management of hepatocellular carcinoma. Rev Gastroenterol Disord 2003;3:8-24.
  12. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005;103:1856-64.
  13. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 2005;16:911-35.
  14. Multi-institutional comparison of 99mTc-MAA lung shunt fraction for transcatheter Y-90 radioembolization. New Orleans, LA: Presented at the Annual Meeting of the Society of Interventional Radiology, 2005.
  15. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. J Am Pharm Assoc (Wash) 2000;40:46-51.
  16. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations and potential complications. Radiographics 2005;25(suppl 1):S41-S55.
  17. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (Thera Sphere): Assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 2006;9:522-29.
  18. Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 2004;19:347-49.
  19. Comparison of postembolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: Trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 2004;3:49-56.
  20. Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer. J Vasc Interv Radiol 2011 Jun;22(6):780-86.
  21. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction. J Vasc Interv Radiol 2010 Aug;21(8):1213-18.
  22. Proximal arterio portal shunting associated with hepatocellular carcinoma: Features revealed by dynamic helical CT. AJR 1999;172:403-07.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.